Biswas Nupur, Kumar Krishna, Mallick Priyanka, Das Subhrangshu, Kamal Izaz Monir, Bose Sarpita, Choudhury Anindita, Chakrabarti Saikat
Structural Biology and Bioinformatics Division, Council for Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology (IICB), Kolkata, India.
Front Genet. 2021 Mar 9;12:626642. doi: 10.3389/fgene.2021.626642. eCollection 2021.
The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-19) pandemic has also affected India, infecting more than 10 million till 31st December 2020 and resulting in more than a hundred thousand deaths. In the absence of an effective vaccine, it is imperative to understand the phenotypic outcome of the genetic variants and subsequently the mode of action of its proteins with respect to human proteins and other bio-molecules. Availability of a large number of genomic and mutational data extracted from the nCoV2 virus infecting Indian patients in a public repository provided an opportunity to understand and analyze the specific variations of the virus in India and their impact in broader perspectives. Non-structural proteins (NSPs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus play a major role in its survival as well as virulence power. Here, we provide a detailed overview of the SARS-CoV2 NSPs including primary and secondary structural information, mutational frequency of the Indian and Wuhan variants, phylogenetic profiles, three-dimensional (3D) structural perspectives using homology modeling and molecular dynamics analyses for wild-type and selected variants, host-interactome analysis and viral-host protein complexes, and drug screening with known antivirals and other drugs against the SARS-CoV2 NSPs isolated from the variants found within Indian patients across various regions of the country. All this information is categorized in the form of a database named, Database of NSPs of India specific Novel Coronavirus (DbNSP InC), which is freely available at http://www.hpppi.iicb.res.in/covid19/index.php.
新型冠状病毒2(nCoV2)于2019年12月在中国湖北省武汉市爆发。它以前所未有的方式在全球范围内持续传播,导致全球封锁,造成了严重的生命损失和经济不稳定。2019冠状病毒病(COVID-19)大流行也影响了印度,截至2020年12月31日,感染人数超过1000万,导致10万多人死亡。在没有有效疫苗的情况下,必须了解基因变异的表型结果,以及随后其蛋白质相对于人类蛋白质和其他生物分子的作用模式。从感染印度患者的nCoV2病毒中提取的大量基因组和突变数据在公共数据库中的可用性,为了解和分析该病毒在印度的特定变异及其更广泛的影响提供了机会。严重急性呼吸综合征冠状病毒2(SARS-CoV2)病毒的非结构蛋白(NSPs)在其生存和毒力方面起着主要作用。在这里,我们详细概述了SARS-CoV2 NSPs,包括一级和二级结构信息、印度和武汉变异体的突变频率、系统发育概况、使用同源建模和分子动力学分析对野生型和选定变异体的三维(3D)结构观点、宿主相互作用组分析和病毒-宿主蛋白复合物,以及使用已知抗病毒药物和其他药物对从印度不同地区患者中分离出的SARS-CoV2 NSPs进行药物筛选。所有这些信息都以一个名为“印度特异性新型冠状病毒NSPs数据库(DbNSP InC)”的数据库形式进行分类,该数据库可在http://www.hpppi.iicb.res.in/covid19/index.php上免费获取。